Cadherin 5 (CDH5) Antikörper

Antigen: Cadherin 5 (CDH5)

Synonyme: UVO, CDHE, ECAD, LCAM, Arc-1, CD324, 7B4, Vec, Cd144, VE-Cad, AA408225, VECAD2, VE-cadherin-2, Pcdh14, VE-cad-2, CDH5, wu:fc88a07

Klonalität: Polyklonal

Wirt: Kaninchen

Reaktivität: Human, Maus, Ratte (Rattus), Rind (Kuh)

Applikation: Immunhistochemie (IHC), Durchflusszytometrie (FACS), Blockierende Antikörper (Inhibition), ELISA, Western Blot (WB), Konfokalmikroskopie (CM)

Produktnummer: ABIN123938

Produktbeschreibung

Weitere Bezeichnung: VE-cadherin

Immunogen: human VE-cadherin

Anwendungen

Buffer: PBS

Lagerung: 2-8 °C until expiry as indicated on the label. After opening aliquote contents and freeze at -20 °C.

Forschungsgebiet: Apoptose/Nekrose, Krebs

Beschränkungen: Nur für Forschungszwecke einsetzbar

Publikationen

Publikationen: Zhang, Wang, Estrov et al.: "Both cell fusion and transdifferentiation account for the transformation of human peripheral blood CD34-positive cells into cardiomyocytes in vivo." in: Circulation, Vol. 110, Issue 25, pp. 3803-7, 2004 (PubMed).

Liu, Cara, Kaur et al.: "LSP1 is an endothelial gatekeeper of leukocyte transendothelial migration." in: The Journal of experimental medicine, Vol. 201, Issue 3, pp. 409-18, 2005 (PubMed).

Lenk, Adams, Lurz et al.: "Therapeutical potential of blood-derived progenitor cells in patients with peripheral arterial occlusive disease and critical limb ischaemia." in: European heart journal, Vol. 26, Issue 18, pp. 1903-9, 2005 (PubMed).

Wang, Johnsen, Mortensen et al.: "Changes in circulating mesenchymal stem cells, stem cell homing factor, and vascular growth factors in patients with acute ST elevation myocardial infarction treated with primary percutaneous coronary intervention." in: Heart (British Cardiac Society), Vol. 92, Issue 6, pp. 768-74, 2006 (PubMed).

Sharpe, Teleron, Li et al.: "The origin and in vivo significance of murine and human culture-expanded endothelial progenitor cells." in: The American journal of pathology, Vol. 168, Issue 5, pp. 1710-21, 2006 (PubMed).